The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care - An observational analysis on non-small-cell lung cancer patients

Keyphrases

• German Hospitals 100%
• Medical Care 100%
• Chemotherapy 100%
• Hospital Care 100%
• Non-small Cell Lung Cancer Patients 100%
• Observational Analysis 100%
• Chemotherapy Side Effects 100%
• Toxicity Management 50%
• ICU Care 50%
• Non-small Cell Lung Cancer (NSCLC) 33%
• Management Costs 33%
• Adverse Drug Reaction 33%
• Second-line Treatment 16%
• Comorbidity 16%
• Economic Implications 16%
• Economic Consequences 16%
• Provider Perspectives 16%
• Treatment Burden 16%
• Immunochemotherapy 16%
• Hospital Stay 16%
• ICU Stay 16%
• Patient Interview 16%
• Chemotherapy Toxicity 16%
• Chart Review 16%
• Stage III-IV 16%
• Life-threatening Complications 16%
• Total Expenditure 16%
• Longitudinal Observational Study 16%
• Cumulative Counts 16%
• Lung Cancer Treatment 16%
• Hospital Days 16%
• Cost Distribution 16%
• Asymmetric Costs 16%
• Tumor Stage 16%
• Eastern Cooperative Oncology Group Performance Status (ECOG PS) 16%
• Day Clinic 16%

Medicine and Dentistry

• Health Care Cost 100%
• Side Effect 100%
• Hospital Care 100%
• Medical Care 100%
• Non Small Cell Lung Cancer 100%
• Infection 40%
• Adverse Drug Reaction 40%
• Immunoglobulin 20%
• Outpatient 20%
• Cancer Staging 20%
• Cancer Therapy 20%
• Oncology 20%
• Observational Study 20%
• Cohort Study 20%
• Comorbidity 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Side Effect 100%
• Non Small Cell Lung Cancer 100%
• Adverse Drug Reaction 22%
• Infection 22%
• Cohort Study 11%
• Observational Study 11%
• Immunoglobulin 11%
• Cancer Staging 11%
• Comorbidity 11%